Publication | Closed Access

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

Megestrol AcetateEndocrine OncologyPhase Ii TrialMedicineGynecologyAdvanced Endometrial CarcinomaOncologyRadiation OncologyGynecology OncologyEndocrine-related Cancer